Sopharma AD Statistics

Total Valuation

Sopharma AD has a market cap or net worth of PLN 2.03 billion. The enterprise value is 2.89 billion.

Market Cap	2.03B
Enterprise Value	2.89B

Important Dates

The last earnings date was Thursday, January 30, 2025.

Earnings Date	Jan 30, 2025
Ex-Dividend Date	Nov 7, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+35.46%
Shares Change (QoQ)	+5.00%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	40.66M

Valuation Ratios

The trailing PE ratio is 11.31.

PE Ratio	11.31
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	1.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.20, with an EV/FCF ratio of 11.87.

EV / Earnings	16.09
EV / Sales	0.65
EV / EBITDA	9.20
EV / EBIT	12.72
EV / FCF	11.87

Financial Position

The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.49.

Current Ratio	1.43
Quick Ratio	0.70
Debt / Equity	0.49
Debt / EBITDA	3.30
Debt / FCF	3.70
Interest Coverage	6.69

Financial Efficiency

Return on equity (ROE) is 10.95% and return on invested capital (ROIC) is 4.39%.

Return on Equity (ROE)	10.95%
Return on Assets (ROA)	3.48%
Return on Invested Capital (ROIC)	4.39%
Return on Capital Employed (ROCE)	8.38%
Revenue Per Employee	836,550
Profits Per Employee	33,348
Employee Count	4,721
Asset Turnover	1.36
Inventory Turnover	4.48

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -6.32% in the last 52 weeks. The beta is -0.04, so Sopharma AD's price volatility has been lower than the market average.

Beta (5Y)	-0.04
52-Week Price Change	-6.32%
50-Day Moving Average	12.98
200-Day Moving Average	13.13
Relative Strength Index (RSI)	45.68
Average Volume (20 Days)	58

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sopharma AD had revenue of PLN 4.50 billion and earned 179.38 million in profits. Earnings per share was 1.01.

Revenue	4.50B
Gross Profit	988.53M
Operating Income	183.83M
Pretax Income	210.17M
Net Income	179.38M
EBITDA	257.25M
EBIT	183.83M
Earnings Per Share (EPS)	1.01

Full Income Statement

Balance Sheet

The company has 83.45 million in cash and 898.82 million in debt, giving a net cash position of -815.37 million.

Cash & Cash Equivalents	83.45M
Total Debt	898.82M
Net Cash	-815.37M
Net Cash Per Share	n/a
Equity (Book Value)	1.84B
Book Value Per Share	10.79
Working Capital	545.63M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 302.14 million and capital expenditures -59.08 million, giving a free cash flow of 243.05 million.

Operating Cash Flow	302.14M
Capital Expenditures	-59.08M
Free Cash Flow	243.05M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 21.97%, with operating and profit margins of 4.09% and 3.99%.

Gross Margin	21.97%
Operating Margin	4.09%
Pretax Margin	4.67%
Profit Margin	3.99%
EBITDA Margin	5.72%
EBIT Margin	4.09%
FCF Margin	5.40%

Dividends & Yields

This stock pays an annual dividend of 0.36, which amounts to a dividend yield of 2.88%.

Dividend Per Share	0.36
Dividend Yield	2.88%
Dividend Growth (YoY)	-89.19%
Years of Dividend Growth	n/a
Payout Ratio	278.20%
Buyback Yield	-35.46%
Shareholder Yield	-32.58%
Earnings Yield	8.84%
FCF Yield	11.98%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Sopharma AD has an Altman Z-Score of 3.1.

Altman Z-Score	3.1
Piotroski F-Score	n/a